Does Dr. Saskin study ischemic strokes?

Yes, Dr. Saskin specializes in researching treatments for ischemic strokes.

What is Revelise, and how is it used in treatment?

Revelise is a medication (alteplase) used to dissolve blood clots and restore blood flow in patients who have had an ischemic stroke.

Who benefits from Dr. Saskin's research?

Patients who suffer from ischemic strokes, particularly older adults and those with additional health issues, benefit from his research findings.

V A Saskin

E.E. Volosevich Arkhangelsk Region First City Clinical Hospital, Arkhangelsk, Russia.

3 publications 2007 – 2025 ORCID

Russia Registries Ischemic Stroke Fibrinolytic Agents Cerebral Hemorrhage

What does V A Saskin research?

V A Saskin studies the impact of a medication called Revelise (alteplase) on patients who have suffered ischemic strokes, which are caused by blocked blood flow to the brain. His research primarily looks at how well this treatment works and how patients recover over time. By analyzing data from a large group of patients in the International PRIMA Study, he helps understand not only the immediate effects of this treatment but also its long-term benefits, especially for older patients and those with additional health conditions.

Key findings

In the International PRIMA Study, nearly half of the 2,202 patients treated with Revelise had good outcomes at discharge, specifically 49.9%.
After 90 days, the percentage of patients with good outcomes increased to 66.4%.
Revelise effectively reduces disabilities associated with strokes, even in patients who are older or have other health issues.

Frequently asked questions

Does Dr. Saskin study ischemic strokes?: Yes, Dr. Saskin specializes in researching treatments for ischemic strokes.
What is Revelise, and how is it used in treatment?: Revelise is a medication (alteplase) used to dissolve blood clots and restore blood flow in patients who have had an ischemic stroke.
Who benefits from Dr. Saskin's research?: Patients who suffer from ischemic strokes, particularly older adults and those with additional health issues, benefit from his research findings.

Publications in plain English

[Fortelyzin for acute ischaemic stroke treatment: an open, prospective, non-interventional, observational study FORPI registry].

2025

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

Shamalov NA, Martynov MY, Gusev EI, Marskaya NA, Khasanova DR +92 more

Plain English
This study looked at how safe and effective the drug Fortelyzin is for treating patients with acute ischemic stroke (AIS). Researchers followed 17,636 patients across 329 centers between March 2021 and October 2024. They found that 61% of patients experienced good outcomes after 90 days, and only 2% had serious bleeding complications, which is similar to results from previous studies. This is important because it supports the use of Fortelyzin for patients suffering from strokes, potentially leading to better treatment options. Who this helps: Patients with acute ischemic stroke and their healthcare providers.

PubMed

[Thrombolytic Therapy for Ischemic Stroke with Revelise: Results of a Two-Year Follow-Up in the International PRIMA Study].

2025

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

Shamalov NA, Khasanova DR, Marchenko SV, Soldatov MA, Azarova AG +46 more

Plain English
This study looked at how well and safely Revelise (alteplase), a medication for treating ischemic stroke (IS), works in real-life situations. It involved 2,202 patients, mostly around 68 years old, and found that nearly half (49.9%) of them had good outcomes when discharged, rising to 66.4% after 90 days. The results showed that Revelise effectively reduces stroke-related disabilities, even in older patients and those with other health issues. Who this helps: This benefits patients who suffer from ischemic strokes and the doctors treating them.

PubMed

[Use of capnography during endoscopic cholecystectomy under different artificial ventilation modes].

2007

Anesteziologiia i reanimatologiia

Suborov EV, Kuz'kov VV, Smetkin AA, Saskin VA, Malyshkin EA +1 more

Plain English
This study looked at how a portable device for monitoring gases in patients helped during gallbladder surgery. In 20 patients, the device provided real-time information about breathing changes, which helped prevent heart and lung problems during the surgery. The device's measurements of carbon dioxide levels were closely related to standard medical tests, showing it was effective. Who this helps: This benefits patients undergoing gallbladder surgery and the doctors performing the procedure.

PubMed

Publication data sourced from PubMed . Plain-English summaries generated by AI. Not medical advice.